Stock VRTX VERTEX PHARMACEUTICALS INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Vertex Pharmaceuticals Incorporated

Equities

VRTX

US92532F1003

Market Closed - Nasdaq
Other stock markets
 01:30:00 27/04/2024 am IST 		5-day change 1st Jan Change
397.5 USD -0.06% Intraday chart for Vertex Pharmaceuticals Incorporated +0.81% -2.31%
26/04 Vertex Pharmaceuticals Gets European Commission Approval for Cystic Fibrosis Treatment for Infants MT
26/04 Vertex Pharmaceuticals Announces European Commission Approval for KALYDECO to Treat Infants with Cystic Fibrosis Ages 1 Month and Older CI

Chart calendar Vertex Pharmaceuticals Incorporated

044d90959d21ab1ece8c39c41e5f7c76.v8FJ7qZSh9t65S2BctygwrMdyV3agU1cjQ8u763PXeY.2LQEmsxn0KM4q2K3Bqj678lLgxzp-GAX-jlxjv-QC7XgtRG4xwezohGHaA~c52d45e51dd6cb67d877a109a8acdf77

Upcoming events on Vertex Pharmaceuticals Incorporated

07/05/2024 01:31 am Q1 2024 Earnings Release
07/05/2024 02:00 am Q1 2024 Earnings Call
15/05/2024 06:30 pm Annual General Meeting
01/08/2024 Q2 2024 Earnings Release (Projected)
30/10/2024 Q3 2024 Earnings Release (Projected)
11/02/2025 Q4 2024 Earnings Release (Projected)
30/04/2025 Q1 2025 Earnings Release (Projected)

Past events on Vertex Pharmaceuticals Incorporated

11/04/2024 02:00 am Acquisition of Alpine Immune Sciences Inc by Vertex Pharmaceuticals Incorporated Call
12/03/2024 01:30 am Leerink Partners Global Biopharma Conference
05/03/2024 09:00 pm TD Cowen Health Care Conference
06/02/2024 03:00 am Q4 2023 Earnings Call
06/02/2024 02:31 am Q4 2023 Earnings Release
30/01/2024 06:30 pm VX-548 Phase 3 Study Results Call
08/01/2024 09:45 pm JPMorgan Healthcare Conference
13/12/2023 06:30 pm VX-548 Phase 2 Study Results Call
12/12/2023 07:30 am American Society of Hematology Meeting - Abstract No:4997
12/12/2023 07:30 am American Society of Hematology Meeting - Abstract No:4999
12/12/2023 06:30 am American Society of Hematology Meeting - Abstract Number #1053
12/12/2023 06:15 am American Society of Hematology Meeting - Abstract Number #1052
12/12/2023 07:30 am American Society of Hematology Meeting - Abstract No:3900
11/12/2023 07:30 am American Society of Hematology Meeting - Abstract No:3678
11/12/2023 07:30 am American Society of Hematology Meeting - Abstract No:3674
14/11/2023 02:00 pm Jefferies London Healthcare Conference - Fireside Chat
09/11/2023 10:30 pm UBS BioPharma Conference - Fireside Chat
07/11/2023 03:00 am Q3 2023 Earnings Call
07/11/2023 02:31 am Q3 2023 Earnings Release
13/09/2023 09:00 pm Morgan Stanley Global Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		4 163
3 759
10.74%		6 206
6 159
0.76%		7 574
7 502
0.97%		8 931
8 933
-0.03%		9 869
9 861
0.08%
10 723

EBITDA
Million USD		Released
Forecast
Spread 		1 893
1 770
6.92%		3 601
3 649
-1.33%		4 470
4 490
-0.46%		4 941
5 101
-3.12%		4 556
4 734
-3.75%
5 298

EBIT
Million USD		Released
Forecast
Spread 		1 786
1 609
11.02%		3 491
3 471
0.58%		4 344
4 345
-0.02%		4 793
4 832
-0.81%		4 375
4 461
-1.94%
4 971

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		1 395
964
44.64%		3 117
2 891
7.82%		2 730
2 761
-1.12%		4 232
4 155
1.86%		4 380
4 415
-0.8%
4 838

Net income
Million USD		Released
Forecast
Spread 		1 177
796
47.91%		2 712
2 608
3.99%		2 342
2 295
2.07%		3 322
3 287
1.06%		3 620
3 574
1.28%
3 857

EPS
USD		Released
Forecast
Spread 		4,51
3,08
46.48%		10,3
9,87
4.24%		9,01
8,80
2.4%		12,8
12,8
0.17%		13,9
13,7
1.52%
14,9

Announcement Date30/01/2001/02/2126/01/2207/02/2305/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		2 073
2 007
3.29%		2 098
2 074
1.14%		2 196
2 132
3.03%		2 334
2 227
4.82%		2 303
2 303
-0.01%		2 375
2 336
1.67%		2 493
2 421
3%		2 484
2 502
-0.73%		2 518
2 515
0.12%
2 579


2 652


2 709


2 778


2 691

EBITDA
Million USD		Released
Forecast
Spread




















1 215
1 255
-3.17%		1 210
1 285
-5.81%
1 256


1 277


1 285


1 250




EBIT
Million USD		Released
Forecast
Spread 		1 124
1 126
-0.15%		1 167
1 188
-1.82%		1 187
1 179
0.67%		1 289
1 210
6.55%		1 150
1 197
-3.94%		902
971
-7.11%		1 148
1 246
-7.89%		1 173
1 239
-5.32%		1 151
1 237
-6.9%
1 201


1 224


1 240


1 270


1 326

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		871
908
-4.05%		955
995
-3.99%		1 024
994
3.05%		1 176
1 038
13.29%		1 077
990
8.81%		892
850
4.85%		1 162
1 132
2.56%		1 179
1 136
3.76%		1 148
1 199
-4.3%
1 185


1 203


1 223


1 229


1 286

Net income
Million USD		Released
Forecast
Spread 		770
720
7%		762
801
-4.8%		811
799
1.47%		931
820
13.42%		819
779
5.08%		700
677
3.43%		916
895
2.29%		1 035
909
13.87%		969
952
1.74%
947


960


971


961


1 016

EPS
USD		Released
Forecast
Spread 		3,00
2,76
8.61%		2,96
3,14
-5.62%		3,13
3,07
1.98%		3,59
3,27
9.92%		3,15
3,09
1.86%		2,69
2,67
0.78%		3,52
3,43
2.58%		3,97
3,48
14.23%		3,71
3,57
4.04%
3,68


3,72


3,77


3,80


3,85

Announcement Date26/01/2205/05/2204/08/2227/10/2207/02/2301/05/2301/08/2306/11/2305/02/24-----

Upcoming sector events for Vertex Pharmaceuticals Incorporated

29/04/2024 HITGEN INC.: Q1 2024 Earnings Release (Projected)
29/04/2024 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
30/04/2024 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
30/04/2024 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
01/05/2024 01:35 am EXELIXIS, INC.: Q1 2024 Earnings Release
01/05/2024 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
01/05/2024 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Vertex Pharmaceuticals Incorporated

26/04/2024 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
26/04/2024 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
26/04/2024 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
26/04/2024 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
26/04/2024 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
26/04/2024 REMEGEN CO., LTD.: Q1 2024 Earnings Release
26/04/2024 01:35 am PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
25/04/2024 04:00 pm SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
25/04/2024 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. VRTX Stock
  4. Calendar Vertex Pharmaceuticals Incorporated